Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer
Open Access
- 29 June 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 9847
Abstract
Natural autoantibody is a key component for immune surveillance function. Regulatory T (Treg) cells play indispensable roles in promoting tumorigenesis via immune escape mechanisms. Both CD25 and FOXP3 are specific markers for Treg cells and their natural autoantibodies may be involved in anticancer activities. This work was designed to develop an in-house enzyme-linked immunosorbent assay (ELISA) to examine plasma natural IgG against CD25 and FOXP3 in non-small cell lung cancer (NSCLC). Compared with control subjects, NSCLC patients had significantly higher levels of plasma IgG for CD25a (Z = −8.05, P < 0.001) and FOXP3 (Z = −4.17, P < 0.001), lower levels for CD25b (Z = −3.58, P < 0.001), and a trend toward lower levels for CD25c (Z = −1.70, P = 0.09). Interestingly, the anti-CD25b IgG assay had a sensitivity of 25.0% against a specificity of 95.0% in an early stage patients (T1N0M0) who showed the lowest anti-CD25b IgG levels among 4 subgroups classified based on staging information. Kaplan-Meier survival analysis showed that patients with high anti-FOXP3 IgG levels had shorter survival than those with low anti-FOXP3 IgG levels (χ2 = 3.75, P = 0.05). In conclusion, anti-CD25b IgG may be a promising biomarker in terms of screening individuals at high risk of lung cancer.Keywords
This publication has 34 references indexed in Scilit:
- Five‐year lung cancer survivalCancer, 2010
- Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammationClinical and Experimental Immunology, 2009
- Small Cell Lung CancerMayo Clinic Proceedings, 2008
- Autoantibodies in lung cancer: possibilities for early detection and subsequent cureThorax, 2008
- Regulatory T cells in cancerBlood, 2006
- CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent mannerJournal of Experimental Medicine, 2005
- Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+regulatory T cellsJournal of Experimental Medicine, 2005
- Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralizationJournal of Experimental Medicine, 2005
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003